These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21303612)

  • 1. Emerging nanomaterial governance systems: the state of play.
    Bergeson LL
    Mol Imaging; 2011 Feb; 10(1):17-27. PubMed ID: 21303612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From cradle-to-grave at the nanoscale: gaps in U.S. regulatory oversight along the nanomaterial life cycle.
    Beaudrie CE; Kandlikar M; Satterfield T
    Environ Sci Technol; 2013 Jun; 47(11):5524-34. PubMed ID: 23668487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology: the next big thing, or much ado about nothing?
    Maynard AD
    Ann Occup Hyg; 2007 Jan; 51(1):1-12. PubMed ID: 17041243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensors as tools for quantitation, nanotoxicity and nanomonitoring assessment of engineered nanomaterials.
    Sadik OA; Zhou AL; Kikandi S; Du N; Wang Q; Varner K
    J Environ Monit; 2009 Oct; 11(10):1782-800. PubMed ID: 19809701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greener nanoscience: a proactive approach to advancing applications and reducing implications of nanotechnology.
    Hutchison JE
    ACS Nano; 2008 Mar; 2(3):395-402. PubMed ID: 19206562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials.
    Thomas K; Sayre P
    Toxicol Sci; 2005 Oct; 87(2):316-21. PubMed ID: 16049265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The legal failure to prevent subclinical developmental toxicity.
    Cranor C
    Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):267-73. PubMed ID: 18226082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is New Zealand's regulation of nanomedical products adequate?
    Moore J
    J Law Med; 2011 Sep; 19(1):112-27. PubMed ID: 21988014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanodermatology: a glimpse of caution just beyond the horizon - part II.
    Nasir A
    Skin Therapy Lett; 2010 Oct; 15(9):4-7. PubMed ID: 20945053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in governance of converging technologies integrated from the nanoscale.
    Roco MC
    Ann N Y Acad Sci; 2006 Dec; 1093():1-23. PubMed ID: 17312249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory oversight of biochemical pesticides by the U.S. Environmental Protection Agency: health effects considerations.
    McClintock JT; Kough JL; Sjoblad RD
    Regul Toxicol Pharmacol; 1994 Feb; 19(1):115-24. PubMed ID: 8159811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximizing safe design of engineered nanomaterials: the NIH and NIEHS research perspective.
    Tinkle SS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):88-98. PubMed ID: 20049833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are environmental regulations keeping up with innovation? A case study of the nanotechnology industry.
    Fairbrother A; Fairbrother JR
    Ecotoxicol Environ Saf; 2009 Jul; 72(5):1327-30. PubMed ID: 19423165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upstream oversight assessment for agrifood nanotechnology: a case studies approach.
    Kuzma J; Romanchek J; Kokotovich A
    Risk Anal; 2008 Aug; 28(4):1081-98. PubMed ID: 18627547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting it right the first time: developing nanotechnology while protecting workers, public health, and the environment.
    Balbus JM; Florini K; Denison RA; Walsh SA
    Ann N Y Acad Sci; 2006 Sep; 1076():331-42. PubMed ID: 17119213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental pediatrics and its impact on government health policy.
    Goldman L; Falk H; Landrigan PJ; Balk SJ; Reigart JR; Etzel RA
    Pediatrics; 2004 Apr; 113(4 Suppl):1146-57. PubMed ID: 15060212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing risks.
    Kasamatsu T; Kohda K
    Regul Toxicol Pharmacol; 2006 Oct; 46(1):100-4. PubMed ID: 16843577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Governance of nanotechnology and nanomaterials: principles, regulation, and renegotiating the social contract.
    Kimbrell GA
    J Law Med Ethics; 2009; 37(4):706-23. PubMed ID: 20122111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splendid one-dimensional nanostructures of zinc oxide: a new nanomaterial family for nanotechnology.
    Wang ZL
    ACS Nano; 2008 Oct; 2(10):1987-92. PubMed ID: 19206442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.